Performance characteristics of three <i>Brucella canis</i> serological assays in the United States.

ABSTRACT: Brucella canis is a zoonotic pathogen of dogs that poses diagnostic challenges. While direct detection of B. canis by PCR or culture is ideal, serologic diagnosis is necessary for identification of carrier animals and can support a clinical diagnosis of brucellosis. Prior to 2022, B. canis seroscreening in the United States was primarily performed using a commercially available rapid slide agglutination test. However, the kit was discontinued by the manufacturer in early 2022, leaving a gap in the availability of commercial B. canis seroassays. The goal of this study was to compare the performance of three B. canis serologic tests that are currently available: VMRD Brucella ovis ELISA, Bionote Anigen Rapid C.Brucella Ab immunochromatographic latera

SUBMITTER: LeCuyer TE 

PROVIDER: S-EPMC11996846 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature